Transcriptomics: How to build a human
- Newcastle University, United Kingdom
The manual for human development is written in the genetic code of our DNA. Our genes encode the instructions to make specific types of molecules that are needed to either build the human body or to control its day-to-day operations. The first step in producing these molecules involves the gene being copied, or transcribed, into an RNA molecule. For some genes, this RNA molecule is the end product; for other genes, the RNA molecule must then be translated to produce a protein.
Mistakes, or mutations, in a gene often change the RNA or protein produced, and even the smallest of changes can have far-reaching effects. For example, if these mutations affect molecules that are needed when a human embryo is developing in the womb, they can lead to severe abnormalities that are collectively called congenital disorders. A cleft palate is a relatively common example of a congenital disorder, and affects one in every 700 babies born each year (Forrester and Merz, 2004; Parker et al., 2010). Similarly, mutations that result in genes being active at the wrong time, or in the wrong cells in a developing embryo, can also lead to congenital disorders. In addition, exposure to toxic or infectious agents can also be a cause. This is exemplified by the drug thalidomide, which was administered to pregnant women between 1956 and 1962, and has caused severe birth defects in around 10,000 children worldwide (McBride, 1961).
Understanding why organs sometimes form incorrectly is challenging, largely because tissue from developing human embryos is rarely available for study. Instead, research has tended to extrapolate information from multiple sources, including individuals born with specific disorders, animal models and cell-based laboratory models of development and disease (Azamian and Lalani, 2016; Moretti et al., 2013; Kelly, 2016).
Some studies have investigated which genes are expressed in developing human embryos by looking at the RNA molecules produced at a given time. These “transcriptomics” studies, however, have tended to look at the embryo as a whole (Fang et al., 2010), or to focus on specific organs and tissues in more developed embryos (van den Berg et al., 2015; Slieker et al., 2015). Consequently, little was known about the formation and early development of organs – a process called organogenesis – in humans.
Over the past year or so, data on this crucial process has started to emerge. First, in mid-2015, a study described the transcriptional profiles of human embryos from different developmental stages (Roost et al., 2015). Now, in eLife, Neil Hanley and co-workers – from the University of Manchester and the Central Manchester University Hospitals NHS Foundation Trust – report transcriptomics data obtained during human organogenesis (Gerrard et al., 2016). The human embryonic material used in the study was collected according to the Codes of Practice of the UK Human Tissue Authority (HTA, 2016).
Hanley and co-workers – who include Dave Gerrard and Andrew Berry as joint first authors – looked at the RNA molecules found in organs and tissues from fifteen separate sites in human embryos. These sites included the thyroid, liver, stomach, brain, heart and adrenal gland. Gerrard et al. were then able to integrate this data into a sort of atlas that mapped the activity level of developmental genes across the embryo. This in turn allowed them to identify eleven groups of genes that were expressed differently in the different organs and tissues examined. Gerrard et al. refer to these groups of genes as metagenes and the activity levels of genes found in each metagene form a kind of transcriptional barcode for each of the different tissue types of the body.
Many cell-based models of development use stem cells from human embryos, or other cells that have been reprogrammed to be more like stem cells (so-called induced pluripotent stem cells; Takahashi et al., 2007). However, these approaches have their limitations (Hrvatin et al., 2014; Patterson et al., 2012), and it is challenging to ensure that stem cells differentiate into completely mature tissues in vitro. Gerrard et al. confirmed that the transcriptional barcode associated with the embryonic liver (metagene 2) was also seen in liver tissue derived from stem cells grown in the laboratory. This suggests that the transcriptional barcodes could be used to check that lab-grown stem cells have differentiated and matured as intended. Moreover, knowing which genes actively direct the cells in embryos to differentiate in specific ways could help other researchers to coax stem cells to become a wider range of tissues in vitro.
The work of Gerrard et al. adds substantially to what is known about the transcriptional profiles of each of the organs and tissues in a developing human embryo, and about the disorders associated with these tissues. Furthermore, their findings complement what we know about the later stages of embryonic development (Roost et al., 2015), and will allow a greater understanding of the distinct events that occur during human development and disease.
The findings by Hanley, Gerrard, Berry and colleagues have great implications for improving stem cell research. They will also undoubtedly aid research into diseases that develop at later stages of development, which has proved particularly challenging so far. Might we be on the cusp of completing the last pages of the ‘how to build a human’ manual? If so, soon we may finally be able to generate mature tissues more routinely in vitro and unravel the unknown mechanisms of development and disease.
References
-
Cytogenomic aberrations in congenital cardiovascular malformationsMolecular Syndromology 7:51–61.https://doi.org/10.1159/000445788
-
Transcriptome analysis of early organogenesis in human embryosDevelopmental Cell 19:174–184.https://doi.org/10.1016/j.devcel.2010.06.014
-
Descriptive epidemiology of oral clefts in a multiethnic population, Hawaii, 1986-2000The Cleft Palate-Craniofacial Journal 41:622–628.https://doi.org/10.1597/03-089.1
-
BookCardiac development and animal models of congenital heart defectsIn: S Rickert-Sperling, RG Kelly, DJ Driscoll, editors. Congenital Heart Diseases: The Broken Heart. Vienna: Springer. pp. 3–9.
-
Pluripotent stem cell models of human heart diseaseCold Spring Harbor Perspectives in Medicine 3:a014027.https://doi.org/10.1101/cshperspect.a014027
-
Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006Birth Defects Research Part A: Clinical and Molecular Teratology 88:1008–1016.https://doi.org/10.1002/bdra.20735
-
Defining the nature of human pluripotent stem cell progenyCell Research 22:178–193.https://doi.org/10.1038/cr.2011.133
-
DNA methylation landscapes of human fetal developmentPLOS Genetics 11:e1005583.https://doi.org/10.1371/journal.pgen.1005583
Article and author information
Author details
Publication history
- Version of Record published: August 24, 2016 (version 1)
Copyright
© 2016, Mellough et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,023
- views
-
- 281
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Transcriptomics: How to build a human
eLife 5:e19826.
https://doi.org/10.7554/eLife.19826
Further reading
-
- Developmental Biology
Inhibitory G alpha (GNAI or Gαi) proteins are critical for the polarized morphogenesis of sensory hair cells and for hearing. The extent and nature of their actual contributions remains unclear, however, as previous studies did not investigate all GNAI proteins and included non-physiological approaches. Pertussis toxin can downregulate functionally redundant GNAI1, GNAI2, GNAI3, and GNAO proteins, but may also induce unrelated defects. Here, we directly and systematically determine the role(s) of each individual GNAI protein in mouse auditory hair cells. GNAI2 and GNAI3 are similarly polarized at the hair cell apex with their binding partner G protein signaling modulator 2 (GPSM2), whereas GNAI1 and GNAO are not detected. In Gnai3 mutants, GNAI2 progressively fails to fully occupy the sub-cellular compartments where GNAI3 is missing. In contrast, GNAI3 can fully compensate for the loss of GNAI2 and is essential for hair bundle morphogenesis and auditory function. Simultaneous inactivation of Gnai2 and Gnai3 recapitulates for the first time two distinct types of defects only observed so far with pertussis toxin: (1) a delay or failure of the basal body to migrate off-center in prospective hair cells, and (2) a reversal in the orientation of some hair cell types. We conclude that GNAI proteins are critical for hair cells to break planar symmetry and to orient properly before GNAI2/3 regulate hair bundle morphogenesis with GPSM2.
-
- Computational and Systems Biology
- Developmental Biology
Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.
